(Bloomberg) A Vivus Inc. (VVUS) pill that is supposed to provide erections within 15 minutes, about half the time or less than Pfizer (PFE) Inc.’s Viagra, won U.S. regulatory approval.
The Food and Drug Administration today cleared the erectile dysfunction treatment, called Stendra, the agency said in a statement. Erectile dysfunction is the inability to get or keep an erection firm enough for sexual intercourse.
The drug, known chemically as avanafil, is the sole product on the market for Mountain View, California-based Vivus, which is seeking a partner to sell the medicine in the U.S. New York- based Pfizer’s Viagra, the top-selling erectile dysfunction pill with $2 billion in sales last year, works in 30 minutes to an hour, according to the drug’s website.
Community: Because what the world really needs is faster erections.
[Click the title, above, to post a comment.]